Drive better commercial outcomes with a comprehensive evidence generation strategy
Bringing a medical product to market requires more than just clinical trial data. It demands a comprehensive integrated evidence planning strategy that addresses the evidence needs of all stakeholders, including regulators, payers, healthcare professionals, and patients.
Developing an Integrated Evidence Generation Plan (IEGP) is a strategic approach that transforms asset development by:
- Aligning cross-functional teams around shared goals
- Optimizing resource allocation and reducing development risks
- Generating compelling evidence for all stakeholders
- Accelerating time-to-market and enhancing commercial success
Integrated evidence planning is an iterative process that begins early in development and continues throughout the product lifecycle. It ensures that data collection serves a specific purpose, contributing to the overall goal of demonstrating product value.
Facilitate collaboration and improve internal alignment with a partnership approach
At Parexel, we have a proven track record of IEGP development and delivery for organizations of all sizes, from big pharma to small and emerging biotech. Our global expertise and multidisciplinary teams align with the internal functions of life sciences companies, allowing us to offer comprehensive support. We provide:
- Early-stage strategy development
- Tactical planning and execution of evidence programs
- Function-specific support
- Advisory services for plan validation
Our approach helps companies navigate complex regulatory and reimbursement landscapes, harness the power of RWE, and develop effective stakeholder communication strategies.
By partnering with Parexel to develop and deliver integrated evidence planning, companies can unlock the full potential of their assets, optimize development processes and improve commercial outcomes in an increasingly competitive market.
Our experts
Sangeeta Budhia
Senior Vice President, Pricing & Market Access
Mike D’Ambrosio
Senior Vice President and Global Head, Real World Research
Vaneet Nayar
Senior Director, Real-World Evidence (RWE)
Cecil Nick
Vice President, Technical, Regulatory Consulting
Nichola Gokool
Vice President, Customer Strategy and Innovation, Medical Communications
Playbook
Streamlining success: How integrated evidence planning transforms asset development
Feb 27, 2025
Blog
Integrated evidence planning and RWE: Realizing value throughout the development lifecycle
May 13, 2025
Blog
Transforming evidence generation: How predictive AI can optimize clinical development
Sep 3, 2024